Boothbay Fund Management’s ProKidney PROK Stock Holding History

Boothbay Fund Management’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,448	Closed	-$203K	–	2532
2022 Q2	$203K	Sell	20,448 -40,392	-66%	-$399K	0.01%	1741
2022 Q1	$602K	Buy	60,840 +38,008	+166%	+$375K	0.01%	1191
2021 Q4	$226K	Buy	22,832 +1,804	+9%	+$17.8K	0.01%	1426
2021 Q3	$206K	Buy	21,028 +3,178	+18%	+$31.3K	0.01%	1566
2021 Q2	$180K	Buy	+17,850	New	+$180K	0.01%	1561

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Boothbay Fund Management's PROK Position: Q3 2022 in Review

Boothbay Fund Management sold out of ProKidney (PROK) in Q3 2022, closing a stake of 20,448 shares — an estimated $203K sold.

Boothbay Fund Management first reported a position in PROK in Q2 2021 and held it in 5 quarters. The position peaked at $602K in Q1 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

Boothbay Fund Management reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
Boothbay Fund Management sold 20,448 ProKidney shares in Q3 2022, an estimated $203K.
Boothbay Fund Management first reported a position in ProKidney in Q2 2021 and held it in 5 quarters.
Boothbay Fund Management's ProKidney position peaked at $602K in Q1 2022.
18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.